H
Hemant Shah
Researcher at University Health Network
Publications - 8
Citations - 949
Hemant Shah is an academic researcher from University Health Network. The author has contributed to research in topics: Liver biopsy & Sofosbuvir. The author has an hindex of 6, co-authored 8 publications receiving 716 citations. Previous affiliations of Hemant Shah include Centre for Mental Health.
Papers
More filters
Journal ArticleDOI
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens,Pietro Andreone,Giuseppe Mazzella,Simone I. Strasser,Christopher L. Bowlus,Pietro Invernizzi,J.P.H. Drenth,Paul J. Pockros,Jaroslaw Regula,Ulrich Beuers,Michael Trauner,David Jones,Annarosa Floreani,Simon Hohenester,Velimir A. Luketic,Mitchell L. Shiffman,K.J. van Erpecum,Victor Vargas,Catherine Vincent,Gideon M. Hirschfield,Hemant Shah,Bettina E. Hansen,Keith D. Lindor,Hanns-Ulrich Marschall,Kris V. Kowdley,R. Hooshmand-Rad,T. Marmon,S. Sheeron,R. Pencek,Leigh MacConell,Mark Pruzanski,David Shapiro +31 more
TL;DR: Obeticholic acid administered with ursodiol or as monotherapy for 12 months in patients with primary biliary cholangitis resulted in decreases from baseline in alkaline phosphatase and total bilirubin levels that differed significantly from the changes observed with placebo.
Journal ArticleDOI
Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia
Joel S. Emery,Magdalena Kuczynski,Danie La,Saeed Almarzooqi,Matthew Kowgier,Matthew Kowgier,Hemant Shah,David Wong,Harry L A Janssen,Jordan J. Feld +9 more
TL;DR: DAAs resulted in high rates of SVR in patients with cryoglobulinemia, suggesting a delay to clinical response particularly in those with severe/life-threatening vasculitis, and further follow-up will be required to determine if clinical improvement continues after viral clearance.
Journal ArticleDOI
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection
Mahmoud Abu-Amara,Orlando Cerocchi,Gurtej Malhi,Suraj Sharma,Colina Yim,Hemant Shah,David Wong,Harry L.A. Janssen,Jordan J. Feld +8 more
TL;DR: Although all models predicted the risk of HCC, models that incorporated parameters of liver function or cirrhosis (CU-H CC/GAG-HCC) were most accurate.
Journal ArticleDOI
Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy.
TL;DR: A patient with chronic hepatitis C, immune thrombocytopenia, and splenic marginal zone lymphoma who, after eradication of HCV with sofosbuvir and ribavirin, exhibited complete remission of both hematologic conditions is described.
Journal ArticleDOI
Psychiatric Care During Hepatitis C Treatment: The Changing Role of Psychiatrists in the Era of Direct-Acting Antivirals
TL;DR: A 52-year-old single Caucasian man was diagnosed with hepatitis C virus (HCV) infection nearly two decades ago after routine testing revealed an elevated alanine transaminase (ALT) level and was confirmed to have sustained virological response.